Supernus Pharm (SUPN) Misses Q1 Loss Views
Tweet Send to a FriendGet Alerts SUPN Hot Sheet
Trade SUPN Now!
Supernus Pharm (NASDAQ: SUPN) reported Q1 EPS of ($1.51), $0.02 worse than the analyst estimate of ($1.49).
After adjustment for a 4-for-1 reverse split, the first-quarter loss was $6.05 per share.
For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
After adjustment for a 4-for-1 reverse split, the first-quarter loss was $6.05 per share.
For earnings history and earnings-related data on Supernus Pharm (SUPN) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
- Taomee Holdings Ltd. (TAOM) Misses Q1 EPS by 2c; Guides Q2 Sales
- Hormel Foods Corp. (HRL) Misses Q1 EPS by 3c; Maintains Outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
